Infu System Holdings, Inc INFU
We take great care to ensure that the data presented and summarized in this overview for InfuSystem Holdings, Inc is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding INFU
View all-
Black Rock Inc. New York, NY1.24MShares$11.9 Million0.0% of portfolio
-
Minerva Advisors LLC Bala Cynwyd, PA1.03MShares$9.79 Million7.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA976KShares$9.31 Million0.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN810KShares$7.73 Million0.53% of portfolio
-
First Eagle Investment Management, LLC802KShares$7.65 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny576KShares$5.49 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX569KShares$5.43 Million0.0% of portfolio
-
Awm Investment Company, Inc. New York, NY562KShares$5.36 Million0.71% of portfolio
-
Meros Investment Management, LP Dallas, TX477KShares$4.55 Million2.19% of portfolio
-
Invenire Partners, LP Ridgefield, CT467KShares$4.45 Million100.0% of portfolio
Latest Institutional Activity in INFU
Top Purchases
Top Sells
About INFU
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
Insider Transactions at INFU
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 09
2025
|
Jerod Funke EVP-Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,669
-16.43%
|
$33,021
$9.61 P/Share
|
|
Oct 09
2025
|
Jerod Funke EVP-Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+35.89%
|
-
|
|
Sep 23
2025
|
Carrie Lachance President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
19,675
-7.81%
|
$196,750
$10.22 P/Share
|
|
Sep 23
2025
|
Carrie Lachance President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+16.56%
|
-
|
|
Aug 22
2025
|
Scott Shuda Director |
SELL
Open market or private sale
|
Direct |
5,752
-5.77%
|
$51,768
$9.67 P/Share
|
|
Jul 07
2025
|
Scott Shuda Director |
SELL
Other acquisition or disposition
|
Direct |
2,242
-2.2%
|
-
|
|
May 28
2025
|
Kenneth D. Eichenbaum Director |
BUY
Open market or private purchase
|
Direct |
2,000
+25.0%
|
$10,000
$5.18 P/Share
|
|
May 19
2025
|
Ronald T Hundzinski Director |
BUY
Open market or private purchase
|
Direct |
5,000
+50.0%
|
$30,000
$6.09 P/Share
|
|
May 17
2025
|
Carrie Lachance President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,090
-2.93%
|
$36,540
$6.15 P/Share
|
|
May 17
2025
|
Carrie Lachance President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,727
+7.86%
|
-
|
|
May 17
2025
|
Barry G Steele Executive VP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,946
-6.57%
|
$35,676
$6.15 P/Share
|
|
May 17
2025
|
Barry G Steele Executive VP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,636
+13.09%
|
-
|
|
May 17
2025
|
Richard Dilorio Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
19,509
-4.17%
|
$117,054
$6.15 P/Share
|
|
May 17
2025
|
Richard Dilorio Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,909
+8.05%
|
-
|
|
May 17
2025
|
Addam Chupa Executive VP and CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,660
-7.53%
|
$21,960
$6.15 P/Share
|
|
May 17
2025
|
Addam Chupa Executive VP and CIO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+17.06%
|
-
|
|
May 16
2025
|
Carrie Lachance President and CEO |
BUY
Open market or private purchase
|
Direct |
1,967
+1.02%
|
$11,802
$6.1 P/Share
|
|
May 15
2025
|
Carrie Lachance President and CEO |
BUY
Open market or private purchase
|
Direct |
1,165
+0.62%
|
$6,990
$6.0 P/Share
|
|
May 14
2025
|
Barry G Steele Executive VP and CFO |
BUY
Open market or private purchase
|
Direct |
3,000
+3.76%
|
$15,000
$5.76 P/Share
|
|
Mar 07
2025
|
Richard Dilorio Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
17,976
-4.07%
|
$107,856
$6.18 P/Share
|
Last 12 Months Summary
| Exercise of conversion of derivative security | 120K shares |
|---|---|
| Grant, award, or other acquisition | 50K shares |
| Open market or private purchase | 13.1K shares |
| Payment of exercise price or tax liability | 76.5K shares |
|---|---|
| Other acquisition or disposition | 2.24K shares |
| Open market or private sale | 5.75K shares |